| Zum Hauptmenu. | Zum Bereichsmenu. | Zur Metanavigation. | Zur Suche. | Direkt zum Inhalt.
For WACKER's most recent press releases click here.
For fiscal 2008, Wacker Chemie AG posted new records for both sales and net income.
As part of its ongoing investment in biotech, WACKER recently opened a new process-development building for the production of pharmaceutical proteins, or biologics, in Jena (Germany).
Wacker Chemie AG has mid-term plans to construct a new hyperpure polycrystalline silicon facility in the US and has purchased land in the State of Tennessee for this purpose.
Wacker Chemie AG’s preliminary 2008 figures show that sales and operating results (EBITDA) both surpassed prior-year levels.
At the European Coatings Show (ECS) in Nuremberg from March 31 to April 2, 2009, the Munich-based WACKER Group will be appearing under the slogan “Inspired by Excellence.”